11
Views
92
CrossRef citations to date
0
Altmetric
Mammalian Genetic Models with Minimal or Complex Phenotypes

Proapoptotic BH3-Only Bcl-2 Family Member Bik/Blk/Nbk Is Expressed in Hemopoietic and Endothelial Cells but Is Redundant for Their Programmed Death

, , , , &
Pages 1570-1581 | Received 09 Nov 2003, Accepted 18 Nov 2003, Published online: 27 Mar 2023

REFERENCES

  • Adams, J. M. 2003. Ways of dying: multiple pathways to apoptosis. Genes Dev. 17:2481–2495.
  • Amanna, I. J., Clise-Dwyer K., Nashold F. E., Hoag K. A., and Hayes C. E.. 2001. Cutting edge: A/WySnJ transitional B cells overexpress the chromosome 15 proapoptotic Blk gene and succumb to premature apoptosis. J. Immunol. 167:6069–6072.
  • Bouillet, P., Cory S., Zhang L.-C., Strasser A., and Adams J. M.. 2001. Degenerative disorders caused by Bcl-2 deficiency are prevented by loss of its BH3-only antagonist Bim. Dev. Cell 1:645–653.
  • Bouillet, P., Metcalf D., Huang D. C. S., Tarlinton D. M., Kay T. W. H., Köntgen F., Adams J. M., and Strasser A.. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735–1738.
  • Bouillet, P., Purton J. F., Godfrey D. I., Zhang L.-C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J. M., and Strasser A.. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415:922–926.
  • Boyd, J. M., Gallo G. J., Elangovan B., Houghton A. B., Malstrom S., Avery B. J., Ebb R. G., Subramanian T., Chittenden T., Lutz R. J., and Chinnadurai G.. 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921–1928.
  • Cheng, E. H., Wei M. C., Weiler S., Flavell R. A., Mak T. W., Lindsten T., and Korsmeyer S. J.. 2001. BCL-2, BCL-xL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8:705–711.
  • Church, G. M., and Gilbert W.. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991–1995.
  • Cory, S., and Adams J. M.. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2:647–656.
  • Cory, S., Huang D. C. S., and Adams J. M.. The Bcl-2 family: role in cell survival and oncogenesis. Oncogene, in press.
  • Coultas, L., Huang D. C. S., Adams J. M., and Strasser A.. 2002. Pro-apoptotic BH3-only Bcl-2 family members in vertebrate model organisms suitable for genetic experimentation. Cell Death Differ. 9:1163–1166.
  • Cui, C., Wani M. A., Wight D., Kopchick J., and Stambrook P. J.. 1994. Reporter genes in transgenic mice. Transgenic Res. 3:182–194.
  • Dimmeler, S., and Zeiher A. M.. 2000. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87:434–439.
  • Enders, A., Bouillet P., Puthalakath H., Xu Y., Tarlinton D. M., and Strasser A.. 2003. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198:1119–1126.
  • Fisher, S. A., Langille B. L., and Srivastava D.. 2000. Apoptosis during cardiovascular development. Circ. Res. 87:856–864.
  • Gerber, H. P., Dixit V., and Ferrara N.. 1998. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273:13313–13316.
  • Han, J., Sabbatini P., and White E.. 1996. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:5857–5864.
  • Hegde, R., Srinivasula S. M., Ahmad M., Fernandes-Alnemri T., and Alnemri E. S.. 1998. Blk, a BH3-containing mouse protein that interacts with Bcl-2 and Bcl-xL, is a potent death agonist. J. Biol. Chem. 273:7783–7786.
  • Huang, D. C. S., and Strasser A.. 2000. BH3-only proteins—essential initiators of apoptotic cell death. Cell 103:839–842.
  • Ito, M., and Yoshioka M.. 1999. Regression of the hyaloid vessels and pupillary membrane of the mouse. Anat. Embryol. (Berlin) 200:403–411.
  • Jeffers, J. R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K. H., Han J., Chittenden T., Ihle J. N., McKinnon P. J., Cleveland J. L., and Zambetti G. P.. 2003. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4:321–328.
  • Jiang, A., and Clark E. A.. 2001. Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J. Immunol. 166:6025–6033.
  • Lam, K. P., and Rajewsky K.. 1998. Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo. Proc. Natl. Acad. Sci. USA 95:13171–13175.
  • Lang, R. A., and Bishop J. M.. 1993. Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74:453–462.
  • Lindsten, T., Ross A. J., King A., Zong W., Rathmell J. C., Shiels H. A., Ulrich E., Waymire K. G., Mahar P., Frauwirth K., Chen Y., Wei M., Eng V. M., Adelman D. M., Simon M. C., Ma A., Golden J. A., Evan G., Korsmeyer S. J., MacGregor G. R., and Thompson C. B.. 2000. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 6:1389–1399.
  • Marsden, V., and Strasser A.. 2003. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21:71–105.
  • Matsuzaki, Y., Nakayama K.-I., Nakayama K., Tomita T., Isoda M., Loh D. Y., and Nakauchi H.. 1997. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell. Blood 89:853–862.
  • Nagata, M., Nakauchi H., Nakayama K.-I., Nakayama K., Loh D., and Watanabe T.. 1996. Apoptosis during an early stage of nephrogenesis induces renal hypoplasia in bcl-2-deficient mice. Am. J. Pathol. 148:1601–1611.
  • Nakayama, K., Nakayama K.-I., Negishi I., Kuida K., Sawa H., and Loh D. Y.. 1994. Targeted disruption of bcl-2αβ in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91:3700–3704.
  • Newton, K., Harris A. W., and Strasser A.. 2000. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 19:931–941.
  • Ogilvy, S., Metcalf D., Gibson L., Bath M. L., Harris A. W., and Adams J. M.. 1999. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood 94:1855–1863.
  • O'Reilly, L. A., Cullen L., Visvader J., Lindeman G., Print C., Bath M. L., Huang D. C. S., and Strasser A.. 2000. The pro-apoptotic BH3-only protein Bim is expressed in hemopoietic, epithelial, neuronal and germ cells. Am. J. Pathol. 157:449–461.
  • O'Reilly, L. A., Print C., Hausmann G., Moriishi K., Cory S., Huang D. C. S., and Strasser A.. 2001. Tissue expression and subcellular localization of the pro-survival molecule Bcl-w. Cell Death Differ. 8:486–494.
  • Print, C. G., Loveland K. L., Gibson L., Meehan T., Stylianou A., Wreford N., de Kretser D., Metcalf D., Köntgen F., Adams J. M., and Cory S.. 1998. Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc. Natl. Acad. Sci. USA 95:12424–12431.
  • Puthalakath, H., and Strasser A.. 2002. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9:505–512.
  • Schwenk, F., Baron U., and Rajewsky K.. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23:5080–5081.
  • Sentman, C. L., Shutter J. R., Hockenbery D., Kanagawa O., and Korsmeyer S. J.. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879–888.
  • Strasser, A., Harris A. W., and Cory S.. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889–899.
  • Strasser, A., O'Connor L., and Dixit V. M.. 2000. Apoptosis signaling. Annu. Rev. Biochem. 69:217–245.
  • Strasser, A., Whittingham S., Vaux D. L., Bath M. L., Adams J. M., Cory S., and Harris A. W.. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88:8661–8665.
  • Suzuki, M., Youle R. J., and Tjandra N.. 2000. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103:645–654.
  • Veis, D. J., Sorenson C. M., Shutter J. R., and Korsmeyer S. J.. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229–240.
  • Verma, S., Budarf M. L., Emanuel B. S., and Chinnadurai G.. 2000. Structural analysis of the human pro-apoptotic gene Bik: chromosomal localization, genomic organization and localization of promoter sequences. Gene 254:157–162.
  • Villunger, A., Michalak E. M., Coultas L., Müllauer F., Böck G., Ausserlechner M. J., Adams J. M., and Strasser A.. 2003. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302:1036–1038.
  • Wang, H. U., Chen Z. F., and Anderson D. J.. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741–753.
  • Zong, W. X., Lindsten T., Ross A. J., MacGregor G. R., and Thompson C. B.. 2001. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:1481–1486.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.